Researchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the cells more effective cancer killers.
Scientists at the School of Medicine have discovered a defect in immune cells known as “killer T cells” that explains their inability to destroy cancer tumors. The researchers believe that repairing this defect could make the cells much better cancer killers. Further, they predict their discovery could be used within three to five years to help identify patients who will best respond to cancer therapies.
[Read more]
- Education
- Research
- Research Home
- Research Departments
- Research Offices
- Research Centers
- Cancer Center
- Cardiovascular Research Center
- Carter Immunology Center
- Center for Behavioral Health & Technology
- Center for Brain Immunology & Glia
- Center for Diabetes Technology
- Center for Immunity, Inflammation & Regenerative Medicine
- Center for Membrane & Cell Physiology
- Center for Research in Reproduction
- Myles H. Thaler Center for AIDS & Human Retrovirus Research
- Child Health Research Center (Pediatrics)
- Division of Perceptual Studies
- Research News: The Making of Medicine
- Research Core Facilities
- Other Research Programs
- Clinical
- Clinical Home
- Anesthesiology
- Dermatology
- Emergency Medicine
- Family Medicine
- Medicine
- Neurology
- Neurosurgery
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Otolaryngology
- Pathology
- Pediatrics
- Physical Medicine & Rehabilitation
- Plastic Surgery, Maxillofacial, & Oral Health
- Psychiatry & Neurobehavioral Sciences
- Radiation Oncology
- Radiology & Medical Imaging
- Surgery
- Urology
- UVA Health: Patient Care
- Diversity
- Faculty
- News
- About